Summary
We have developed several series of potent and selective small molecule inhibitors of SSAO (AOC3/VAP-1) that also block trafficking of leukocytes to sites of inflammation. Blocking of SSAO-mediated leukocyte adhesion has recently been shown efficacious in several models of inflammatory diseases. We have examined the potential of SSAO inhibitors in neurological diseases, having previously demonstrated the efficacy of SSAO inhibition in a rat model of stroke. Here we show the effect of the small molecule SSAO inhibitor LJP 1207 (IC50 human SSAO 17 nM; ratio IC50 SSAO:MAO >5000), on relapsing-remitting experimental autoimmune encephalomyelitis (EAE), a mouse model that shares many characteristics with human multiple sclerosis. Clinical efficacy was observed when dosing with LJP 1207 was initiated either at the peak of initial flare or during remission. These data demonstrate the potential clinical benefit of small molecule anti-SSAO therapy in this model.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L Airas J Mikkola JM Vainio I Elovaara DJ Smith (2006) ArticleTitleElevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis J Neuroimmunol 177 132–135 10.1016/j.jneuroim.2006.05.014 Occurrence Handle10.1016/j.jneuroim.2006.05.014 Occurrence Handle1:CAS:528:DC%2BD28Xns1Skt7k%3D Occurrence Handle16806498
B Engelhardt (2006) ArticleTitleMolecular mechanism involved in T cell migration across the blood-brain barrier J Neural Transm 113 477–485 10.1007/s00702-005-0409-y Occurrence Handle10.1007/s00702-005-0409-y Occurrence Handle1:CAS:528:DC%2BD28XislWksLc%3D Occurrence Handle16550326
AM Ercolini SD Miller (2006) ArticleTitleMechanism of immunopathology in murine models of central nervous system demyelinating disease J Immunol 176 3293–3298 Occurrence Handle1:CAS:528:DC%2BD28XitVSksL4%3D Occurrence Handle16517694
EM Frohman MK Racke CS Raine (2006) ArticleTitleMultiple Sclerosis — the plaque and it’s pathogenesis New Engl J Med 354 942–955 10.1056/NEJMra052130 Occurrence Handle10.1056/NEJMra052130 Occurrence Handle1:CAS:528:DC%2BD28XitVertLc%3D Occurrence Handle16510748
SM Kerfoot MU Normal BM Lapointe CS Bonder L Zbytnuik P Kubes (2006) ArticleTitleReevaluation of P-selectin and α4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis J Immunol 176 6225–6234 Occurrence Handle1:CAS:528:DC%2BD28XktVWnsr8%3D Occurrence Handle16670333
BL Kleinschmidt-DeMasters KL Tyler (2005) ArticleTitlePML complicating treatment with natalizumab and IFN-β1a for multiple sclerosis New Engl J Med 353 369–374 10.1056/NEJMoa051782 Occurrence Handle10.1056/NEJMoa051782 Occurrence Handle1:CAS:528:DC%2BD2MXms1KntrY%3D Occurrence Handle15947079
M Laschinger B Englehardt (2000) ArticleTitleInteraction of α4 integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro J Neuroimmunol 102 32–43 10.1016/S0165-5728(99)00156-3 Occurrence Handle10.1016/S0165-5728(99)00156-3 Occurrence Handle1:CAS:528:DyaK1MXotVKqtr0%3D Occurrence Handle10626664
M Merinen H Irjala M Salmi I Jaakkola A Hanninen S Jalkanen (2005) ArticleTitleVascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse Am J Pathol 166 793–800 Occurrence Handle1:CAS:528:DC%2BD2MXivVOmsLg%3D Occurrence Handle15743791
DH Miller OA Khan WA Sheremata LD Blumhardt GPA Rice MA Libonati AJ Willmer-Hulme CM Dalton KA Miszkiel PW O’Connor (2003) ArticleTitleA controlled trial of natalizumab for relapsing multiple sclerosis J Engl J Med 348 15–23 10.1056/NEJMoa020696 Occurrence Handle10.1056/NEJMoa020696 Occurrence Handle1:CAS:528:DC%2BD3sXhtlCntg%3D%3D
MU Norman P Kubes (2005) ArticleTitleTherapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy Microcirculation 12 91–98 Occurrence Handle10.1080/10739680590896036 Occurrence Handle1:CAS:528:DC%2BD2MXitlCktLc%3D Occurrence Handle15804977
M Salmi S Jalkanen (1992) ArticleTitleA 90 kDa endothelial cell molecule mediating lymphocyte binding in humans Science 257 1407–1409 10.1126/science.1529341 Occurrence Handle10.1126/science.1529341 Occurrence Handle1:CAS:528:DyaK38XmtlSksL0%3D Occurrence Handle1529341
M Salmi S Jalkanen (2001) ArticleTitleVAP-1: an adhesion and an enzyme Trends Immunol 22 211–216 10.1016/S1471-4906(01)01870-1 Occurrence Handle10.1016/S1471-4906(01)01870-1 Occurrence Handle1:CAS:528:DC%2BD3MXjslWjsr4%3D Occurrence Handle11274927
M Salmi GG Yegutkin R Lehvonen K Koskinen T Salminen S Jalkanen (2001) ArticleTitleA cell surface amine oxidase directly controls lymphocyte migration Immunity 14 265–275 10.1016/S1074-7613(01)00108-X Occurrence Handle10.1016/S1074-7613(01)00108-X Occurrence Handle1:CAS:528:DC%2BD3MXis1ehurg%3D Occurrence Handle11290336
LM Salter-Cid EY Wang AM O’Rourke A Miller H Gao L Huang A Garcia MD Linnik (2005) ArticleTitleAnti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase J Pharmacol Exp Ther 315 553–562 10.1124/jpet.105.089649 Occurrence Handle10.1124/jpet.105.089649 Occurrence Handle1:CAS:528:DC%2BD2MXhtFyhsbfN Occurrence Handle16081681
L Steinman (2005) ArticleTitleBlocking adhesion molecules as therapy for MS: natalizumab Nature Rev Drug Disc 4 510–519 10.1038/nrd1752 Occurrence Handle10.1038/nrd1752 Occurrence Handle1:CAS:528:DC%2BD2MXks12ktrg%3D
CM Stolen F Marttila-Ichihara K Koskinen GG Yegutkin R Turja P Bono M Skurnik A Hanninen S Jalkanen M Salmi (2005) ArticleTitleAbsence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo Immunity 22 105–115 10.1016/j.immuni.2004.12.006 Occurrence Handle10.1016/j.immuni.2004.12.006 Occurrence Handle1:CAS:528:DC%2BD2MXht1Cgsb0%3D Occurrence Handle15664163
BE Theien CL Vanderlugt TN Eagar C Nickerson-Nutter R Nazareno VK Kuchroo SD Miller (2001) ArticleTitleDiscordant effects of anti-VLA-4 treatment before or after onset of relapsing EAE J Clin Invest 107 995–1006 10.1172/JCI11717 Occurrence Handle10.1172/JCI11717 Occurrence Handle1:CAS:528:DC%2BD3MXivVKjtL0%3D Occurrence Handle11306603
EY Wang H Gao L Salter-Cid J Zhang L Huang EM Podar A Miller J Zhao AM O’Rourke MD Linnik (2006) ArticleTitleDesign, synthesis and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity J Med Chem 49 2166–2173 10.1021/jm050538l Occurrence Handle10.1021/jm050538l Occurrence Handle1:CAS:528:DC%2BD28XitlOjurY%3D Occurrence Handle16570912
H-L Xu L Salter-Cid MD Linnik EY Wang C Paisansathan DL Pellegrino (2006) ArticleTitleVascular adhesion protein-1 plays an important role in post ischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia J Pharmacol Exp Ther 317 19–29 10.1124/jpet.105.096958 Occurrence Handle10.1124/jpet.105.096958 Occurrence Handle1:CAS:528:DC%2BD28XjsVWmsbs%3D Occurrence Handle16339390
T Yednock C Cannon L Fritz F Sanchez-Madrid L Steinman N Karin (1992) ArticleTitlePrevention of EAE by antibodies against α4β1 integrin Nature 92 63–66 10.1038/356063a0 Occurrence Handle10.1038/356063a0
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Rourke, A., Wang, E., Salter-Cid, L. et al. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J Neural Transm 114, 845–849 (2007). https://doi.org/10.1007/s00702-007-0699-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0699-3